These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8677453)

  • 1. Ifosfamide in non-small cell lung cancer.
    Johnson DH
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):7-10. PubMed ID: 8677453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
    Hoffman PC; Masters GA; Drinkard LC; Krauss SA; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):11-5. PubMed ID: 8677441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide in the treatment of small cell lung cancer.
    Ettinger DS
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):2-6. PubMed ID: 8677443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide in the treatment of soft tissue sarcomas.
    Connelly EF; Budd GT
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifosfamide in the treatment of non-small cell lung cancer.
    Ettinger DS
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):31-8. PubMed ID: 2539646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.
    Soh LT; Tan EH; Ang PT
    Singapore Med J; 1998 Aug; 39(8):357-8. PubMed ID: 9844496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
    Li DX; Chen XB
    Ai Zheng; 2002 Apr; 21(4):412-5. PubMed ID: 12452023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifosfamide and paclitaxel combinations for the treatment of advanced non-small cell lung cancer.
    Shepherd FA; Eisenhauer E
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):2-7. PubMed ID: 9535204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.
    Masters GA; Hoffman PC; Drinkard LC; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):8-14. PubMed ID: 9535205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer.
    Shepherd FA; Latreille J; Paul K; Eisenhauer E
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):84-90. PubMed ID: 9007130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide-based three-drug combination regimens in non-small cell lung cancer.
    Vokes EE; Masters GA; Mauer AM; Hoffman PC; Watson S; Golomb HM
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):19-22. PubMed ID: 9535207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ifosfamide in small cell lung cancer.
    Loehrer PJ
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):40-4. PubMed ID: 8711501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
    Pratt CB
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer.
    Vokes EE; Mauer AM; Hoffman PC; Masters G; Watson S; Golomb HM
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-67-S12-69. PubMed ID: 9331125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
    Palackdharry CS
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):78-83. PubMed ID: 8677455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide in non-small cell lung cancer: a review.
    Eberhardt W; Niederle N
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):40-8. PubMed ID: 1329211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago.
    Vokes EE; Hoffman PC; Masters GA; Golomb HM; Drinkard LC; Krauss SA
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):15-8. PubMed ID: 8711496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.